Neoplasms

"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor ID	D009369
MeSH Number(s)	C04
Concept/Terms	Neoplasms Neoplasms Neoplasia Neoplasias Neoplasm Tumors Tumor Cancer Cancer Cancers Malignant Neoplasms Malignant Neoplasm Neoplasm, Malignant Neoplasms, Malignant Malignancy Malignancies Benign Neoplasms Benign Neoplasms Neoplasms, Benign Benign Neoplasm Neoplasm, Benign

Below are MeSH descriptors whose meaning is more general than "Neoplasms".

Diseases [C]
Neoplasms [C04]

Below are MeSH descriptors whose meaning is more specific than "Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1181 publications over 31 distinct years, with a maximum of 73 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	4	3	7
1997	1	2	3
1998	3	1	4
1999	1	4	5
2000	4	4	8
2001	8	4	12
2002	8	7	15
2003	14	3	17
2004	19	7	26
2005	13	5	18
2006	18	8	26
2007	27	8	35
2008	34	12	46
2009	24	7	31
2010	34	10	44
2011	29	7	36
2012	29	11	40
2013	47	6	53
2014	47	10	57
2015	41	5	46
2016	48	7	55
2017	62	9	71
2018	45	13	58
2019	57	8	65
2020	54	8	62
2021	61	5	66
2022	66	2	68
2023	58	2	60
2024	57	16	73
2025	53	12	65
2026	7	2	9

Below are the most recent publications written about "Neoplasms" by people in Profiles.

West SM, Meyer MRU, Patterson C, Ruffin MT, Calo W, Pagoto S, Conroy D, Doerksen S, Sciamanna CN, Gordon B, Garrow G, Werts-Pelter SJ, Schmitz KH. Increasing physical activity in rural Pennsylvanians: The PA moves trial study protocol for a cluster randomized controlled trial. Contemp Clin Trials. 2026 Jul; 166:108348.

View in: PubMed
Sim JA, Yu J, Bae J, Seo JW, Kim JH, Yoo SH, Keam B. Temporal association of palliative care consultation with the trajectory of broad-spectrum antibiotic use at the end of life in advanced cancer: A nationwide linked cohort study. Int J Infect Dis. 2026 Aug; 169:108779.

View in: PubMed
Kim HJ, Sim JA, Lee SY, Yoo SH. Association between palliative care consultation and care transition outcomes among hospitalized advanced cancer patients. JNCI Cancer Spectr. 2026 May 09; 10(3).

View in: PubMed
Sim JA, Kim D, Yoo SH, Cho W, Hwang IY, Lee SY, Kim KH, Kim MS, Kim YJ, Jung EH, Lee J, Cho B. Social Capital and Financial Toxicity in Caregivers of Patients With Advanced Cancer: Associations With Health-Related Quality of Life and Psychological Distress. J Natl Compr Canc Netw. 2026 May; 24(5):155-162.

View in: PubMed
Johnson ML, Patel MR, Falchook GS, Koyama T, Gutierrez M, Awad MM, Piha-Paul SA, Friedman CF, Satoh T, Okamoto N, Singh J, Yoshizuka N, Windish HP, Qian M, Tran BP, Doi T. Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial. Lancet Oncol. 2026 Apr; 27(4):491-501.

View in: PubMed
Kim HJ, Sim JA, Yoo SH. Opioid prescribing patterns at the end of life in an asian advanced cancer cohort: differences by palliative care consultation status. Support Care Cancer. 2026 Mar 30; 34(4).

View in: PubMed
Yu JX, Suh JM, Popova KD, Garcia K, Joshi T, Culbertson B, Spinelli JB, Subramanyam V, Lou K, Charbonneau T, Shokat KM, Weissman J, Goodarzi H. The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations. Nat Cancer. 2026 Mar; 7(3):522-537.

View in: PubMed
Chung HK, Liu C, Battu A, Jambor AN, Pratt BM, Xie F, Riesenberg BP, Casillas E, Sun M, Landoni E, Li Y, Ye Q, Joo D, Green J, Syed Z, Brown NJ, Smith M, Ma S, Tan S, Chick B, Tripple V, Wang ZA, Wang J, Mcdonald B, He P, Yang Q, Chen T, Varanasi SK, LaPorta MA, Mann TH, Chen D, Hoffmann F, Ho J, Modliszewski J, Williams A, Liu Y, Wang Z, Liu J, Gao Y, Hu Z, Cho UH, Liu L, Wang Y, Hargreaves DC, Dotti G, Savoldo B, Thaxton JE, Milner JJ, Kaech SM, Wang W. Atlas-guided discovery of transcription factors for T cell programming. Nature. 2026 03; 651(8107):1077-1087.

View in: PubMed
Daee D, Behm M, Marcus PM, Rosenfield SM, Rotunno M, Cronin KA, Kobrin SC, Gillanders EM. The Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2026 Feb 03; 35(2):193-197.

View in: PubMed
Zhan X, Xiao H, Wang Q, Luo J, Ma L, Zhang X, Tang J, Meng X. Natural killer cell nano-engagers drive ferroptosis-immunomodulation synergy via inhibition of the Interleukin-6-JAK2-STAT3 Axis. J Control Release. 2026 Feb 10; 390:114581.

View in: PubMed

People

Explore

Similar Concepts

Top Journals